JP2010504755A5 - - Google Patents

Info

Publication number

JP2010504755A5

JP2010504755A5 JP2009530419A JP2009530419A JP2010504755A5 JP 2010504755 A5 JP2010504755 A5 JP 2010504755A5 JP 2009530419 A JP2009530419 A JP 2009530419A JP 2009530419 A JP2009530419 A JP 2009530419A JP 2010504755 A5 JP2010504755 A5 JP 2010504755A5

Authority

JP

Japan

Prior art keywords

antibody

seq

amino acid

variable region

chain variable

Prior art date

2007-09-28

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 101000872077 Homo sapiens Delta-like protein 4 Proteins 0.000 claims description 38
• 102000044457 human DLL4 Human genes 0.000 claims description 38
• 150000001413 amino acids Chemical class 0.000 claims description 19
• 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 claims description 17
• 206010028980 Neoplasm Diseases 0.000 claims description 13
• 201000011510 cancer Diseases 0.000 claims description 11
• 102000040430 polynucleotide Human genes 0.000 claims description 11
• 108091033319 polynucleotide Proteins 0.000 claims description 11
• 239000002157 polynucleotide Substances 0.000 claims description 11
• 239000003814 drug Substances 0.000 claims description 10
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 9
• 101000737793 Homo sapiens Cerebellar degeneration-related antigen 1 Proteins 0.000 claims description 8
• 229940124597 therapeutic agent Drugs 0.000 claims description 8
• 239000013612 plasmid Substances 0.000 claims description 7
• 210000004027 cell Anatomy 0.000 claims description 6
• 210000004408 hybridoma Anatomy 0.000 claims description 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
• 239000002246 antineoplastic agent Substances 0.000 claims description 3
• 229940127089 cytotoxic agent Drugs 0.000 claims description 3
• 238000004519 manufacturing process Methods 0.000 claims description 3
• 239000008194 pharmaceutical composition Substances 0.000 claims description 3
• 230000009870 specific binding Effects 0.000 claims description 3
• 239000013598 vector Substances 0.000 claims description 3
• 239000003937 drug carrier Substances 0.000 claims description 2
• 210000000130 stem cell Anatomy 0.000 claims description 2
• 206010006187 Breast cancer Diseases 0.000 claims 1
• 208000026310 Breast neoplasm Diseases 0.000 claims 1
• 206010009944 Colon cancer Diseases 0.000 claims 1
• 101100499372 Homo sapiens DLL1 gene Proteins 0.000 claims 1
• 101000928513 Homo sapiens Delta-like protein 3 Proteins 0.000 claims 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
• 101100387419 Mus musculus Dll4 gene Proteins 0.000 claims 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
• 208000029742 colonic neoplasm Diseases 0.000 claims 1
• 102000053255 human DLL3 Human genes 0.000 claims 1
• 201000005202 lung cancer Diseases 0.000 claims 1
• 208000020816 lung neoplasm Diseases 0.000 claims 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
• 210000004898 n-terminal fragment Anatomy 0.000 claims 1
• 201000002528 pancreatic cancer Diseases 0.000 claims 1
• 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
• 229920001184 polypeptide Polymers 0.000 claims 1
• 108090000765 processed proteins & peptides Proteins 0.000 claims 1
• 102000004196 processed proteins & peptides Human genes 0.000 claims 1
• 210000004897 n-terminal region Anatomy 0.000 description 12
• NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 6
• 230000000890 antigenic effect Effects 0.000 description 6
• 238000006467 substitution reaction Methods 0.000 description 6
• 108700041286 delta Proteins 0.000 description 5
• 238000000034 method Methods 0.000 description 3
• 239000000203 mixture Substances 0.000 description 3
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
• 238000012258 culturing Methods 0.000 description 2
• 239000013610 patient sample Substances 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• 230000004614 tumor growth Effects 0.000 description 2
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical group FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
• 102000005650 Notch Receptors Human genes 0.000 description 1
• 108010070047 Notch Receptors Proteins 0.000 description 1
• 230000027455 binding Effects 0.000 description 1
• 230000000694 effects Effects 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 229960002949 fluorouracil Drugs 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 229960004768 irinotecan Drugs 0.000 description 1
• UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 1
• 230000004807 localization Effects 0.000 description 1
• 238000001959 radiotherapy Methods 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 230000003248 secreting effect Effects 0.000 description 1
• 230000001131 transforming effect Effects 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1